WallStreetZenWallStreetZen

NASDAQ: CLOV
Clover Health Investments Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CLOV

Based on 3 analysts offering 12 month price targets for Clover Health Investments Corp.
Min Forecast
$1.50+21.95%
Avg Forecast
$2.10+70.73%
Max Forecast
$3.00+143.9%

Should I buy or sell CLOV stock?

Based on 3 analysts offering ratings for Clover Health Investments Corp.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
1 analysts 33.33%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CLOV stock forecasts and price targets.

CLOV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Citigroup
Bottom 17%
17
HoldMaintains$1.80+46.34%2022-11-16
SVB Leerink
Top 18%
83
HoldMaintains$1.50+21.95%2022-11-08
Credit Suisse
Bottom 8%
8
SellMaintains$3.00+143.90%2022-08-09

1 of 1

Forecast return on equity

Is CLOV forecast to generate an efficient return?
Company
N/A
Industry
29.79%
Market
13.26%

Forecast return on assets

Is CLOV forecast to generate an efficient return on assets?
Company
N/A
Industry
9.15%

CLOV earnings per share forecast

What is CLOV's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.88
Avg 2 year Forecast
-$0.43
Avg 3 year Forecast
-$0.11

CLOV revenue forecast

What is CLOV's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$4.4B+45.15%
Avg 2 year Forecast
$5.8B+93.26%
Avg 3 year Forecast
$7.3B+144.07%
CLOV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CLOV revenue growth forecast

How is CLOV forecast to perform vs Healthcare Plans companies and vs the US market?
Company
34.55%
Industry
8.85%
Market
9.2%
CLOV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CLOV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CLOV vs Healthcare Plan Stocks

TickerPricePrice TargetUp/downsideConsensus
CLOV$1.23$2.10+70.73%Hold
BHG$0.89$2.46+176.07%Hold
MPLN$1.22$1.68+37.95%Hold
OSCR$3.79$5.63+48.42%Hold
MRAI$0.89$2.50+180.90%Strong Buy
View Top Healthcare Plan Stocks

Clover Health Investments Stock Forecast FAQ

Is Clover Health Investments Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CLOV) stock is to Hold CLOV stock.

Out of 3 analysts, 0 (0%) are recommending CLOV as a Strong Buy, 0 (0%) are recommending CLOV as a Buy, 2 (66.67%) are recommending CLOV as a Hold, 1 (33.33%) are recommending CLOV as a Sell, and 0 (0%) are recommending CLOV as a Strong Sell.

If you're new to stock investing, here's how to buy Clover Health Investments stock.

What is CLOV's earnings growth forecast for 2023-2025?

(NASDAQ: CLOV) Clover Health Investments's forecast annual earnings growth rate of N/A is not forecast to beat the US Healthcare Plans industry's average forecast earnings growth rate of 15.62%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 21.89%.

Clover Health Investments's earnings in 2023 is -$441,999,000.On average, 2 Wall Street analysts forecast CLOV's earnings for 2023 to be -$420,590,498, with the lowest CLOV earnings forecast at -$425,369,936, and the highest CLOV earnings forecast at -$411,031,623. On average, 1 Wall Street analyst forecast CLOV's earnings for 2024 to be -$205,515,812, with the lowest CLOV earnings forecast at -$205,515,812, and the highest CLOV earnings forecast at -$205,515,812.

In 2025, CLOV is forecast to generate -$52,573,812 in earnings, with the lowest earnings forecast at -$52,573,812 and the highest earnings forecast at -$52,573,812.

What is CLOV's revenue growth forecast for 2023-2025?

(NASDAQ: CLOV) Clover Health Investments's forecast annual revenue growth rate of 34.55% is forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 8.85%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.

Clover Health Investments's revenue in 2023 is $3,009,932,000.On average, 2 Wall Street analysts forecast CLOV's revenue for 2023 to be $2,088,090,830,356, with the lowest CLOV revenue forecast at $2,041,015,760,897, and the highest CLOV revenue forecast at $2,135,165,899,815. On average, 1 Wall Street analysts forecast CLOV's revenue for 2024 to be $2,780,150,987,741, with the lowest CLOV revenue forecast at $2,780,150,987,741, and the highest CLOV revenue forecast at $2,780,150,987,741.

In 2025, CLOV is forecast to generate $3,511,070,361,558 in revenue, with the lowest revenue forecast at $3,511,070,361,558 and the highest revenue forecast at $3,511,070,361,558.

What is CLOV's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CLOV) forecast ROA is N/A, which is lower than the forecast US Healthcare Plans industry average of 9.15%.

What is CLOV's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CLOV price target, the average CLOV price target is $2.10, with the highest CLOV stock price forecast at $3.00 and the lowest CLOV stock price forecast at $1.50.

On average, Wall Street analysts predict that Clover Health Investments's share price could reach $2.10 by Nov 16, 2023. The average Clover Health Investments stock price prediction forecasts a potential upside of 70.73% from the current CLOV share price of $1.23.

What is CLOV's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: CLOV) Clover Health Investments's current Earnings Per Share (EPS) is -$0.98. On average, analysts forecast that CLOV's EPS will be -$0.88 for 2023, with the lowest EPS forecast at -$0.89, and the highest EPS forecast at -$0.86. On average, analysts forecast that CLOV's EPS will be -$0.43 for 2024, with the lowest EPS forecast at -$0.43, and the highest EPS forecast at -$0.43. In 2025, CLOV's EPS is forecast to hit -$0.11 (min: -$0.11, max: -$0.11).

What is CLOV's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CLOV) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.